The Bull Case For Canadian Solar (CSIQ) Could Change Following US Patent Win And Notes Offering

Canadian Solar Inc. -2.05%

Canadian Solar Inc.

CSIQ

13.36

-2.05%

  • Earlier in January 2026, Canadian Solar Inc. secured a decisive win at the US Patent Trial and Appeal Board, which invalidated all Maxeon Solar Pte. Ltd. patent claims at issue and followed the company’s completion of a US$200,000,000 convertible senior unsecured notes offering due 2031.
  • This legal outcome highlights Canadian Solar’s dependence on an extensive intellectual property portfolio and its capacity to defend core solar and storage technologies in major markets.
  • Next, we’ll examine how this legal victory, particularly the invalidation of Maxeon’s asserted patents, influences Canadian Solar’s investment narrative.

These 10 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

What Is Canadian Solar's Investment Narrative?

To own Canadian Solar today, you have to believe in its ability to convert a large, low-margin solar and storage footprint into more durable profitability, while managing policy, financing and competitive pressures. The recent PTAB win against Maxeon removes an overhang around key US patents and reinforces the idea that its IP portfolio is an operational asset, not just a legal cost center, which could support confidence in its reshoring push and new product launches. Paired with the US$200,000,000 convertible notes, it also slightly shifts the near term story toward balance sheet flexibility and execution risk on new North American capacity, rather than headline legal risk. That said, the share price volatility and thin net margins mean the biggest questions still sit squarely around earnings quality and cash generation.

However, one key financial risk here is easier to miss at first glance. Canadian Solar's share price has been on the slide but might be dropping deeper into value territory. Find out whether it's a bargain at this price.

Exploring Other Perspectives

CSIQ 1-Year Stock Price Chart
CSIQ 1-Year Stock Price Chart
The Simply Wall St Community’s six fair value views on Canadian Solar stretch from US$7 to US$38, underlining how differently people see the same earnings and IP story. While some focus on patent wins and reshoring as potential catalysts, others remain cautious about leverage and historically thin margins, which could materially influence how any recovery in profitability is ultimately priced.

Explore 6 other fair value estimates on Canadian Solar - why the stock might be worth as much as 86% more than the current price!

Build Your Own Canadian Solar Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Canadian Solar research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
  • Our free Canadian Solar research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Canadian Solar's overall financial health at a glance.

Seeking Other Investments?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

  • We've found 13 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
  • AI is about to change healthcare. These 109 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.